Long-term efficacy of infliximab in patients with ulcerative colitis - an observational study from a single center in Norway

被引：0
|
作者：
Lerang, F. [1 ]
Henriksen, M. [1 ]
Jelsness-Jorgensen, L. -P. [1 ]
机构：
[1] Cent Hosp Ostfold, Med, Sarpsborg, Norway
来源：
JOURNAL OF CROHNS & COLITIS | 2017年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P408
引用
收藏
页码：S284 / S285
页数：2
相关论文
共 50 条
  • [31] Infliximab for active ulcerative colitis: a prospective study on patients' short-term response and long-term outcome.
    Nieminen, U.
    Turunen, U.
    Arkkila, P.
    Sipponen, T.
    Farkkila, M.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S401 - S401
  • [32] Efficacy and safety of long-term thiopurine maintenance treatment for ulcerative colitis in Turkey: A single-center experience
    Ozgenc, Funda
    Karakoyun, Miray
    Ecevit, Cigdem
    Hekimci, Hamiyet
    Tasci, Ezgi Kiran
    Erdemir, Gulin
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2018, 29 (06): : 650 - 654
  • [33] Long-term infliximab therapy for ulcerative colitis in real clinical practice
    Knyazev, O. V.
    Parfenov, A. I.
    Kagramanova, A. V.
    Ruchkina, I. N.
    Shcherbakov, P. L.
    Shakhpazyan, N. K.
    Noskova, K. K.
    Ivkina, T. I.
    Khomeriki, S. G.
    TERAPEVTICHESKII ARKHIV, 2016, 88 (08) : 46 - 52
  • [34] Long-term Efficacy and Safety of Azathioprine in Ulcerative Colitis
    Sood, Ruchit
    Ansari, Saqib
    Clark, Tanya
    Hamlin, P. John
    Ford, Alexander C.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 (02): : 191 - 197
  • [35] Infliximab is effective as a long-term treatment for ulcerative colitis: Results of the act long term extension
    Reinisch, Walter
    Sandborn, William J.
    Rutgeerts, Paul
    Feagan, Brian G.
    Rachmilewitz, Daniel
    Hanauer, Stephen B.
    Lichtenstein, Gary R.
    De villiers, Willem J.
    Olson, Allan
    Zhang, Hongyan
    Johanns, Jewel
    Thorne, Nicole
    Colombel, Jean-Frederic
    Present, Daniel H.
    Sands, Bruce E.
    GASTROENTEROLOGY, 2007, 132 (04) : A147 - A147
  • [36] Long-term outcome of infliximab treatment in chronic active ulcerative colitis: a Swedish multicentre study of 250 patients
    Angelison, L.
    Almer, S.
    Eriksson, A.
    Karling, P.
    Fagerberg, U.
    Halfvarson, J.
    Thorn, M.
    Bjork, J.
    Hindorf, U.
    Lofberg, R.
    Bajor, A.
    Hjortswang, H.
    Hammarlund, P.
    Grip, O.
    Torp, J.
    Marsal, J.
    Hertervig, E.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (04) : 519 - 532
  • [37] Long-term outcome of treatment with infliximab in patients with steroid refractory acute severe ulcerative colitis
    Walker, N. M.
    Croft, A.
    Radford-Smith, G.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 64 - 64
  • [38] Comparison of long-term outcomes of infliximab and adalimumab in biologic-naive patients with ulcerative colitis
    Durak, M. B.
    Baspinar, B.
    Guven, I. E.
    Kivrakoglu, F.
    Kilic, V.
    Kosar, K.
    Erdogan, C.
    Yuksel, I.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I547 - I547
  • [39] Long-Term Risk of Colectomy in Patients with Severe Ulcerative Colitis Responding to Intravenous Corticosteroids or Infliximab
    De Cristofaro, Elena
    Salvatori, Silvia
    Marafini, Irene
    Zorzi, Francesca
    Alfieri, Norma
    Musumeci, Martina
    Calabrese, Emma
    Monteleone, Giovanni
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (06)
  • [40] Comparison of long-term outcomes of infliximab and adalimumab in biologic-naive patients with ulcerative colitis
    Durak, M. B.
    Baspinar, B.
    Guven, I. E.
    Kivrakoglu, F.
    Kilic, V.
    Kosar, K.
    Erdogan, C.
    Yuksel, I.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I547 - I547
12345